[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351380-105":59,"doc-detail-351380-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","adipor1ampk-axis-suppresses-breast-cancer-across-molecular-subtypes-via-multimodal-cell-death-pathways-including-ferroptosis-and-apoptosis","AdipoR1–AMPK axis suppresses breast cancer across molecular subtypes via multimodal cell death pathways, including ferroptosis and apoptosis","","Adipokine signaling from adipocytes is implicated in cancer progression, but which adipokine receptors are therapeutically actionable and which tumor types respond remain unclear. A pan-cancer transcriptome analysis across 31 tumor types identified AdipoR1 as frequently amplified and overexpressed in breast cancer across molecular subtypes. Functional experiments showed that AdipoR1 activation via AdipoRon suppresses proliferation and migration and induces apoptosis in both HR-positive and triple-negative breast cancer cells. RNA-seq and immunoblotting linked AdipoR1 signaling to ferroptosis and hormone-receptor-associated changes. AdipoR1 activation also enhances chemotherapy efficacy and reduces tumor growth in vivo by promoting necrotic cell death, supporting AdipoR1 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/adipor1ampk-axis-suppresses-breast-cancer-across-molecular-subtypes-via-multimodal-cell-death-pathways-including-ferroptosis-and-apoptosis/351380/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/adipor1ampk-axis-suppresses-breast-cancer-across-molecular-subtypes-via-multimodal-cell-death-pathways-including-ferroptosis-and-apoptosis/351380.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the pan-cancer transcriptome analysis identify about adipokine receptors in breast cancer?","Question",{"text":112,"@type":113},"AdipoR1 was the most frequently amplified and overexpressed adipokine receptor in breast cancer across molecular subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does AdipoR1 stimulation affect breast cancer cell behavior in the study?",{"text":117,"@type":113},"Agonist AdipoRon activates AMPK signaling, suppresses proliferation and migration, and induces apoptosis in both hormone receptor-positive and triple-negative breast cancer cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What cell-death pathways are implicated after AdipoR1 activation?",{"text":121,"@type":113},"RNA-seq and protein-level analyses indicate upregulation of ferroptosis-related genes alongside hormone-receptor-associated changes, supporting multimodal antitumor cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351380,1791353033,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nAdipoR1–AMPK axis suppresses breast cancer across molecular subtypes via multimodal cell death pathways, including ferroptosis and apoptosis  \nShinya Sato 1,2,3 ✉ , Takashi Yamanaka4, Yukako Komori2, Mutsumi Ishida1,2, Yoshiyasu Nakamura1,2, Toshinari Yamashita4 and Yohei Miyagi2,3  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Adipokines secreted by adipocytes have emerged as critical modulators of cancer progression, particularly in obesity-associated malignancies. However, their therapeutic relevance and the tumor types responsive to adipokine pathways remain unclear. To identify adipokine-driven cancers and assess the therapeutic potential of adipokine signaling, we conducted a pan-cancer transcriptome analysis of the expression of various adipokine receptors in 31 tumor types. AdipoR1 was most frequently ampliﬁed and overexpressed in breast cancer across molecular subtypes. In the functional analysis, AdipoR1 stimulation using the agonist AdipoRon activated AMPK signaling, suppressed proliferation and migration, and induced apoptosis in both hormone receptor (HR)-positive (MCF7, T47D) and triple-negative (MDA-MB-231, MDA-MB-468) breast cancer cells. Notably, RNA-Seq analysis revealed that AdipoR1 stimulation upregulated ferroptosis-related genes, DDIT3, HMOX1, and IRE1α, and downregulated proliferationrelated genes, estrogen receptor and TROP2, in breast cancer cell lines. Immunoblotting conﬁrmed these changes at the protein level. AdipoR1 activation enhanced the efﬁcacy of chemotherapeutic agents. In vivo, AdipoRon signiﬁcantly reduced tumor growth and induced necrotic cell death. AdipoR1 activation exerts multimodal antitumor effects by engaging cell death and hormone receptor signaling. These ﬁndings establish AdipoR1 as a valuable therapeutic target in breast cancer and support further |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| development of adipokine receptor-targeting therapies. |  |  |\n|  | Cell Death and Disease (2026)17:384; [https://doi.org/10.1038/s41419-026-08583-7](https://doi.org/10.1038/s41419-026-08583-7) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe tumor microenvironment (TME) comprises cancer cells surrounded by organ-speciﬁc resident and stromal cells such as immune cells, blood vessel cells, ﬁbroblasts, neurons, myocytes, and adipocytes [1–3] . In recent years, the importance of stromal cells interacting with cancer cells in cancer progression has become increasingly evident [4–6] . The cancer-regulatory mechanisms of immune cells, blood vessel cells, and ﬁbroblasts have been identiﬁed, and drugs targeting cancer–stromal interaction mechanisms have been applied in standard cancer therapy [7–10] . The mechanism of action of therapies targeting stromal cells, such as immune and blood vessel cells, differs from that of conventional therapies targeting cancer cells and exerts additive effects when combined with cancer-targeting therapies [11–14] . Therapies targeting stromal cells are essential for improving the efﬁcacy of cancer treatment; however, the roles of certain stromal cells in the TME are still not fully understood, and further research is required to advance cancer treatment.  \nAdipocytes are stromal cells found extensively throughout the body, except in the brain, and they exist in the TME along with cancer cells at nearly all primary and metastatic cancer sites.  \nAdipocytes not only interact directly with cancer cells, but they also secrete various factors that inﬂuence cancer progression [15] . Adipokines are secreted factors unique to adipocytes. More than 30 types of adipokines, including adiponectin and leptin, have been identiﬁed and functionally analyzed [16–18] . Certain adipose-derived secretory factors reportedly affect cancer growth; however, most have only been studied in preliminary in vitro studies using cell lines or in epidemi","cbCaikHWNNtRC5w4","https://ap.wps.com/l/cbCaikHWNNtRC5w4","pdf",4881306,14,"English","# Introduction\n## Adipocytes and adipokines in the tumor microenvironment\n## Clinical rationale for adipokine-targeted therapy\n## Study aim and approach","[{\"question\":\"What did the pan-cancer transcriptome analysis identify about adipokine receptors in breast cancer?\",\"answer\":\"AdipoR1 was the most frequently amplified and overexpressed adipokine receptor in breast cancer across molecular subtypes.\"},{\"question\":\"How does AdipoR1 stimulation affect breast cancer cell behavior in the study?\",\"answer\":\"Agonist AdipoRon activates AMPK signaling, suppresses proliferation and migration, and induces apoptosis in both hormone receptor-positive and triple-negative breast cancer cell lines.\"},{\"question\":\"What cell-death pathways are implicated after AdipoR1 activation?\",\"answer\":\"RNA-seq and protein-level analyses indicate upregulation of ferroptosis-related genes alongside hormone-receptor-associated changes, supporting multimodal antitumor cell death.\"}]","AdipoR1–AMPK axis suppresses breast cancer across molecular subtypes via multimodal cell death pathways, including ferroptosis and apoptosis | PDF",1790093929,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a564ad3538d943787c8745d9b5ccd383.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2683bcc1dfce50ac7a41395c1ea0ff1f.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bfcd3fec134c436465079995ecd64b9a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c151738126e61325d0317bde45fc5972.webp",980,1301]